In Brief: FDA's Drug Abuse Advisory Committee
This article was originally published in The Tan Sheet
Executive Summary
FDA's Drug Abuse Advisory Committee: Will meet Feb. 10 from 8:30 a.m. to 5 p.m. to discuss New Life Health Products' Quit brand silver acetate lozenges for smoking cessation. An open public hearing will take place from 8:30-9:30 a.m.; open committee discussion will begin at 9:30 a.m. and end at 10:30 a.m. for a closed session addressing trade secret information. On Feb. 11, the committee will discuss Carter-Wallace's prescription Soma (carisoprodol) tablets for muscle relaxation; under consideration will be a Drug Enforcement Agency petition regarding scheduling of the drug under the Controlled Substances Act...